Skip to content
Holistic Vive

Holistic Vive

Health is the key to success and happiness

Primary Menu Holistic Vive

Holistic Vive

  • Blood Clotting Healthcare
  • Kidney Healthcare
  • Liver Healthcare
  • Liver Cancer Healthcare
  • Brain Healthcare and Neurology
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • Loss

Loss

Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal
  • Brain Healthcare and Neurology

Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal

admin March 4, 2025 0

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid...

Read MoreRead more about Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal
Ozempic And Other Weight Loss Meds Tied To Increased Risk Of Kidney And Pancreas Problems
  • Kidney Healthcare

Ozempic And Other Weight Loss Meds Tied To Increased Risk Of Kidney And Pancreas Problems

admin January 23, 2025 0

In the world of modern medicine, few phenomena are as captivating as the rise of GLP-1 receptor agonists, the so-called...

Read MoreRead more about Ozempic And Other Weight Loss Meds Tied To Increased Risk Of Kidney And Pancreas Problems
Weight Loss To Itching, Understanding The Symptoms Of Liver Cancer
  • Liver Cancer Healthcare

Weight Loss To Itching, Understanding The Symptoms Of Liver Cancer

admin January 31, 2024 0

Symptoms of liver cancer often appear in the advanced stages.Liver cancer can be classified into two main types: primary and...

Read MoreRead more about Weight Loss To Itching, Understanding The Symptoms Of Liver Cancer

Recent Posts

  • Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • AI in Liver Care Needs Vigilance and Tailoring to Population
  • Kidney Dialysis Equipment Market, In-Depth Analysis
  • KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Archives

Categories

  • Blood Clotting Healthcare
  • Brain Healthcare and Neurology
  • Kidney Healthcare
  • Liver Cancer Healthcare
  • Liver Healthcare

Visit Us

Ohio National Guard

You may have missed

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • Liver Cancer Healthcare

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0
AI in Liver Care Needs Vigilance and Tailoring to Population
  • Liver Healthcare

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0
Kidney Dialysis Equipment Market, In-Depth Analysis
  • Kidney Healthcare

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0
KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • Liver Cancer Healthcare

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
  • Liver Healthcare

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0
Copyright © All rights reserved. | CoverNews by AF themes.